Jelmyto Prices, Coupons, Copay Cards & Patient Assistance
Jelmyto (mitomycin) is a member of the antibiotics/antineoplastics drug class and is commonly used for Urothelial Carcinoma.
The cost for Jelmyto 40 mg ureteral kit is around $26,143 for a supply of 1 kits, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Jelmyto is available as a brand name drug only, a generic version is not yet available. View generic Jelmyto availability for more details.
Jelmyto prices
Ureteral Kit
40 mg
Jelmyto ureteral kit
from $26,142.89
for 1 kits
Quantity | Per unit | Price |
---|---|---|
1 | $26,142.89 | $26,142.89 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Jelmyto Coupons, Copay Cards and Rebates
Jelmyto offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Jelmyto UroGen Support CoPay Program
Eligible commercially insured patients may pay $50 per dose with a maximum savings of $4000; maximum savings of $13,800 per year.
- Applies to:
- Jelmyto
- Number of uses:
- Per prescription per year
Form more information phone: 855-535-6986 or Visit website
Patient Assistance & Copay Programs for Jelmyto
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: UroGen Support
Eligibility requirements:- Determined case by case
- Determined case by case
- FDA-approved diagnosis
- Must be a US resident and treated by a US licensed healthcare provider
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Jelmyto (mitomycin) Pyelocalyceal Solution
More information please phone: 855-535-6986 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Bavencio
Bavencio (avelumab) is a cancer medicine that interferes with the growth and spread of cancer cells ...
Erdafitinib
Erdafitinib systemic is used for bladder cancer, urothelial carcinoma
Avelumab
Avelumab systemic is used for merkel cell carcinoma, renal cell carcinoma, urothelial carcinoma
Enfortumab vedotin
Enfortumab vedotin systemic is used for bladder cancer, urothelial carcinoma
More about Jelmyto (mitomycin)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antibiotics/antineoplastics
- En español